SavedAdd your journal

Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2019 / Cilt: 27 - Sayı: 2

Serum prolidase activity, total oxidant/antioxidant, and nitric oxide levels in patients with esophageal squamous cell carcinoma

Özofagusun skuamöz hücreli karsinomu olan hastalarda serum prolidaz aktivitesi, total oksidan/antioksidan ve nitrik oksit düzeyleri

Cahit BİLGİN
Abidin ŞEHİTOĞULLARI
Halit DEMİR
Fuat SAYIR
Mehmet ASLAN
Ufuk ÇOBANOĞLU
Pages
206–211
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Impairment of antioxidantmechanism with increased prolidase activity and nitric oxidelevels may have a crucial role in the etiopathogenesis ofesophageal squamous cell carcinoma

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: This study aims to assess the prolidase activity,nitric oxide levels, and oxidative status in patients with esophagealsquamous cell carcinoma.Methods: The study included 30 patients with esophagealsquamous cell carcinoma (11 males, 19 females;mean age 61±3 years; range, 28 to 77 years) and 30 healthycontrols (10 males, 20 females; mean age 58±5 years;range, 31 to 73 years).
📊
Key Findings & Data:In addition, the oxidative stress index was calculated.Results: Prominently elevated serum prolidase activity, oxidativestress index values, total oxidant status, and nitric oxide levelswere detected in the patient group (p<0.05).
💡
Conclusion & Impact:Impairment of antioxidantmechanism with increased prolidase activity and nitric oxidelevels may have a crucial role in the etiopathogenesis ofesophageal squamous cell carcinoma
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: This study aims to assess the prolidase activity,nitric oxide levels, and oxidative status in patients with esophagealsquamous cell carcinoma.Methods: The study included 30 patients with esophagealsquamous cell carcinoma (11 males, 19 females;mean age 61±3 years; range, 28 to 77 years) and 30 healthycontrols (10 males, 20 females; mean age 58±5 years;range, 31 to 73 years). Serum prolidase activity, total antioxidantcapacity, total oxidant status, and nitric oxide levels weremeasured. In addition, the oxidative stress index was calculated.Results: Prominently elevated serum prolidase activity, oxidativestress index values, total oxidant status, and nitric oxide levelswere detected in the patient group (p<0.05). Lower totalantioxidant capacity levels were observed in the patient group(p<0.05).Conclusion: Increased oxidant status with increased nitricoxide levels and prolidase activity were found in esophagealsquamous cell carcinoma patients. Impairment of antioxidantmechanism with increased prolidase activity and nitric oxidelevels may have a crucial role in the etiopathogenesis ofesophageal squamous cell carcinoma

Özet

Amaç: Bu çalışmada özofagusun skuamöz hücreli karsinomu olan hastalarda prolidaz aktivitesi, nitrik oksit düzeyleri ve oksidatif durum değerlendirildi. Çalışma planı: Çalışmaya özofagusun skuamöz hücreli karsinomu olan 30 hasta (11 erkek, 19 kadın; ort. yaş 61±3 yıl; dağılım, 28-77 yıl) ve 30 sağlıklı kontrol (10 erkek, 20 kadın; ort. yaş 58±5 yıl; dağılım, 31-73 yıl) dahil edildi. Serum prolidaz aktivitesi, total antioksidan kapasitesi, total oksidan durumu ve nitrik oksit düzeyleri ölçüldü. Ayrıca, oksidatif stres indeksi hesaplandı. Bulgular: Hasta grubunda belirgin şekilde artmış serum prolidaz aktivitesi, oksidatif stres indeksi değerleri, total oksidan durumu ve nitrik oksit düzeyleri saptandı (p<0.05). Hasta grubunda daha düşük total antioksidan kapasitesi düzeyleri gözlendi (p<0.05). Sonuç: Özofagusun skuamöz hücreli karsinomu olan hastalarda artmış nitrik oksit düzeyleri ve prolidaz aktivitesi ile artmış oksidan durumu bulundu. Artmış prolidaz aktivitesi ve nitrik oksit düzeyleri ile antioksidan mekanizma bozukluğu, özofagusun skuamöz hücreli karsinomunun etyopatogenezinde önemli rol oynayabilir.

🔖

Cite This Article

BİLGİN, C., ŞEHİTOĞULLARI, A., DEMİR, H., SAYIR, F., ASLAN, M., ÇOBANOĞLU, U. (2022). Serum prolidase activity, total oxidant/antioxidant, and nitric oxide levels in patients with esophageal squamous cell carcinoma. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 27 - Sayı: 2, 206–211. https://ajindex.com/articles/423750

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Kuwano H, Nakajima M, Miyazaki T, Kato H. Distinctive clinicopathological characteristics in esophageal squamous cell carcinoma. Ann Thorac Cardiovasc Surg 2003;9:6-13
  2. Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, et al. Oesophageal cancer. Nat Rev Dis Primers 2017;3:17048
  3. Chow CK. Cigarette smoking and oxidative damage in the lung. Ann N Y Acad Sci. 1993;686:289-98
  4. Morita M, Kumashiro R, Kubo N, Nakashima Y, Yoshida R, Yoshinaga K, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol 2010;15:126-34
  5. Kubo N, Morita M, Nakashima Y, Kitao H, Egashira A, Saeki H, et al. Oxidative DNA damage in human esophageal cancer: clinicopathological analysis of 8-hydroxydeoxyguanosine and its repair enzyme. Dis Esophagus 2014;27:285-93
  6. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer 2006;6:521-34
  7. Choudhari SK, Chaudhary M, Bagde S, Gadbail AR, Joshi V. Nitric oxide and cancer: a review. World J Surg Oncol 2013;11:118
  8. Surazynski A, Liu Y, Miltyk W, Phang JM. Nitric oxide regulates prolidase activity by serine/threonine phosphorylation. J Cell Biochem 2005;96:1086-94
  9. Aslan M, Duzenli U, Esen R, Soyoral YU. Serum prolidase enzyme activity in obese subjects and its relationship with oxidative stress markers. Clin Chim Acta 2017;473:186-90
  10. Surazynski A, Donald SP, Cooper SK, Whiteside MA, Salnikow K, Liu Y, et al. Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer. 2008;122:1435-40
  11. Celik S, Kızıltan R, Yılmaz EM, Yılmaz Ö, Demir H. Potential diagnostic and prognostic significance of plasma prolidase activity in gastric cancer. Biomark Med 2017;11:319-27
  12. Bayhan Z, Zeren S, Kocak C, Kocak FE, Duzgun SA, Algin MC, et al. Prolidase activity and oxidative stress in patients with breast carcinoma A prospective randomized casecontrolled study. Ann Ital Chir 2016;87:517-24
  13. Camuzcuoglu H, Arioz DT, Toy H, Kurt S, Celik H, Aksoy N. Assessment of preoperative serum prolidase activity in epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2009;147:97-100
  14. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277-85
  15. Erel O. A new automated colorimetric method for measuring total oxidant status.